Virtual Library

Start Your Search

E. Syahruddin

Moderator of

  • +

    MS17 - Imaging Developments (ID 34)

    • Event: WCLC 2013
    • Type: Mini Symposia
    • Track: Imaging, Staging & Screening
    • Presentations: 4
    • +

      MS17.1 - Molecular Imaging - Where Are We and Where Is It Going (ID 536)

      14:00 - 15:30  |  Author(s): T. Akhurst

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      MS17.2 - Standardized Reporting; Guidelines for Imaging Protocols / Interpretation (ID 537)

      14:00 - 15:30  |  Author(s): A. Devaraj

      • Abstract
      • Presentation
      • Slides

      Abstract
      The radiology report forms an essential component of any radiological examination, and an accurate radiology report requires two key components: the detection of abnormalities (if any), and subsequently their interpretation. However, for radiology reports to be useful to the clinician and patient, a third crucial factor is successful communication. In the setting of lung cancer reporting, radiologists rely on their perceptive ability to detect nodules or masses, while interpretation requires knowledge and experience of the appearances, staging and behaviour of lung carcinomas. Improvements in both of the factors have been achieved by developments such as the use of computer aided detection software or maximum intensity projections (MIPs), for example, to detect lung cancer; and the use of internationally recognized documents such as the IASLC lung cancer staging classification which aids radiological interpretation. By comparison, the communication of the radiology report has changed little over the years, and it could be argued that efforts to improve lung cancer detection and staging are diminished without satisfactory communication. Standardized reporting (SR) has been advocated as a tool that can improve the communication of radiology reports, and which may also have benefits in the detection and interpretation of radiological abnormalities. This presentation will review the definitions of SR, and examine its purported benefits and disadvantages. Studies investigating the impact of SR will be reviewed. In particular, its relevance to lung cancer imaging will be highlighted. There is no single definition of what a standardized report should look like, but a key principle is that standardized reports (SRs) follow a pre-defined format. At the most basic level this includes the use of brief headings within a report, such as “clinical information” or “impression”, each of which contains free-text. At the other extreme is the mandatory use of a check-list of itemised headings, and the selection from a list of only pre-defined terms (using standardized language) within these headings, rather than free-text. Itemised headings in a CT structured report of a patient with lung cancer might include tumour morphology, tumour location, tri-dimensional measurements, presence or absence of invasion of structures such as pleura or chest wall, the presence or absence of enlarged lymph nodes recorded for all of the nodal stations, and the presence or absence of metastatic disease in each of the body organs. The hypothesized advantages of SR is that it produces: i) reports that are more accurate, ii) reports that are easier to read and understand, and iii) reports from which it is straightforward to retrieve data for research purposes. It has also been suggested that SRs allow radiologists to better convey uncertainties and likelihoods to clinicians. This is standard practice in mammographic reporting, where abnormalities are given a score between 1(negative) and 5 (highly suggestive of malignancy) and could in theory be extrapolated to the description of lung nodules in a clinical or lung cancer screening setting. The main disadvantages of SR that are put forward include its negative impact on workflow and the interpretation process. Additionally, it is suggested that, in fact, free text can better capture the uncertainties within a radiological examination, as often findings cannot be simply categorized into negative or positive. Unlike standardized reporting, the subject of standardized protocols in lung cancer imaging is perhaps less controversial, but no less important. The protocols used for the imaging of lung cancer can have a significant impact on the accurate staging and treatment planning of lung cancer. Furthermore, the successful implementation of future lung cancer screening programmes will require consistent adherence to low-dose CT acquisition protocols. In the staging of patients with lung cancer, protocols such as the routine reconstruction of multi-planar reformats to better identify tumour invasion are becoming widely adopted. Less agreement exists on imaging pathways. For example, the role of routine brain MRI in lung cancer staging or the possible use of contrast-enhanced PET/CT as a “one-stop shop”.

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      MS17.3 - Correlation of PET, CT and MRI with Pathology and Response (ID 538)

      14:00 - 15:30  |  Author(s): D. Aberle

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      MS17.4 - Radiotracers in Imaging and Therapy of Thoracic Oncology (ID 539)

      14:00 - 15:30  |  Author(s): T. Akhurst

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.



Author of

  • +

    P3.11 - Poster Session 3 - NSCLC Novel Therapies (ID 211)

    • Event: WCLC 2013
    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 1
    • +

      P3.11-022 - Deep Vein Trombosis Among Lung Cancer Patients Using Wells' Score: A Single Institution Experience (ID 2064)

      09:30 - 16:30  |  Author(s): E. Syahruddin

      • Abstract

      Background
      Deep vein thrombosis (DVT) is the common complication found in malignancy. Currently, there were no current diagnosis guideline which could help to identify DVT in lung cancer. This study, is a pilot study to identify and see the magnitude at DVT proportion among lung cancer in our hospital. The objective of this study is to find proportion of deep vein thrombosis among lung cancer patients which is determined by clinical criteria such as Wells’ score in Persahabatan Hospital.

      Methods
      The study design is using a cross-sectional method. We examined 147 patients with pathological confirmed lung cancer who were hospitalized within September 2012 to February 2013. We excluded the lung cancer patients with infection comorbidity. The hemostatis function included PT, APTT, and D dimmer were conducted along with clinical Wells’ score criteria.

      Results
      Seventy eight of 147 sobjects were analyze in this study. They were mostly male (69,2%) with range of ages were 30 –79 years old with predominant age group of 51-60 years old (33,3%). Adenocarcinoma was found in 57,7%. This study found that deep vein thrombosis proportion is 23, 1% using Wells’ score. Clinical characteristics such as gender, age, smoking history, cancer cell type, stage of the diseases, performance status and homeostasis function did not have correlation with DVT whereas the D dimmer >500 have correlation with DVT.

      Conclusion
      The DVT proportion among lung cancer patients in Persahabatan Hospital is similar found in some studies in other countries which are approximately 21%. This study revealed that the simple and practical application of Wells’ score in determining DVT is still have valuable role in daily practice, especially in hospital with limited facility.